• Mon, May 19, 2014
  • Tue, May 20, 2014
  • Wed, May 21, 2014
  • Thu, May 22, 2014
  • Fri, May 23, 2014

Matt Miksic Upgraded (ABT) to Buy on, May 19th, 2014

Matt Miksic of Credit Suisse, Upgraded "Abbott Laboratories" (ABT) to Buy on, May 19th, 2014.

Matt has made no other calls on ABT in the last 4 months.



There is 1 other peer that has a rating on ABT. Out of the 1 peers that are also analyzing ABT, 0 agree with Matt's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matt


  • Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $42 on, Thursday, January 23rd, 2014